Results for tag: "Blastocystis Hominis Diagnostic"

The Blastocystis Hominis Diagnostic market is a segment of the Diagnostics industry that focuses on the detection and identification of Blastocystis Hominis, a single-celled parasite that can cause gastrointestinal symptoms. Diagnostic tests for Blastocystis Hominis are used to detect the presence of the parasite in a patient's stool sample. These tests are used to diagnose and monitor the progress of the infection, as well as to determine the effectiveness of treatment. The Blastocystis Hominis Diagnostic market is highly competitive, with a number of companies offering a range of diagnostic tests. These companies include Bio-Rad Laboratories, GenMark Diagnostics, Hologic, Luminex Corporation, Qiagen, and Thermo Fisher Scientific. Show Less Read more